Wockhardt's WCK 6777 (Ertapenem/Zidebactam) received FDA Fast Track designation for complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.